Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

600 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort.
Colussi O, Voron T, Pozet A, Hammel P, Sauvanet A, Bachet JB, Vaillant JC, Rougier P, Nordlinger B, Berger A, Coriat R, Dousset B, Malka D, André T, Paye F, Aparicio T, Locher C, Cojean Zeleck D, Tchinou L, Bonnetain F, Taieb J. Colussi O, et al. Among authors: taieb j. Eur J Surg Oncol. 2015 Apr;41(4):520-6. doi: 10.1016/j.ejso.2015.01.010. Epub 2015 Jan 24. Eur J Surg Oncol. 2015. PMID: 25680954
[Colorectal cancer: prognostic molecular markers].
Boige V, Malka D, Taïeb J, Pignon JP, Ducreux M. Boige V, et al. Among authors: taieb j. Gastroenterol Clin Biol. 2004 Jan;28(1):21-32. doi: 10.1016/s0399-8320(04)94836-1. Gastroenterol Clin Biol. 2004. PMID: 15041806 Free article. Review. French. No abstract available.
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.
Louvet C, Labianca R, Hammel P, Lledo G, Zampino MG, André T, Zaniboni A, Ducreux M, Aitini E, Taïeb J, Faroux R, Lepere C, de Gramont A; GERCOR; GISCAD. Louvet C, et al. Among authors: taieb j. J Clin Oncol. 2005 May 20;23(15):3509-16. doi: 10.1200/JCO.2005.06.023. J Clin Oncol. 2005. PMID: 15908661 Clinical Trial.
Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: a multicenter phase II study with dose adjustment according to baseline serum bilirubin level.
Boige V, Taïeb J, Hebbar M, Malka D, Debaere T, Hannoun L, Magherini E, Mignard D, Poynard T, Ducreux M. Boige V, et al. Among authors: taieb j. Eur J Cancer. 2006 Mar;42(4):456-9. doi: 10.1016/j.ejca.2005.09.034. Epub 2006 Jan 20. Eur J Cancer. 2006. PMID: 16427779 Clinical Trial.
600 results